Cargando...
The impact of a dose of the angiotensin receptor blocker valsartan on post‐myocardial infarction ventricular remodelling
AIMS: Although clinical guidelines advocate the use of the highest tolerated dose of angiotensin‐converting enzyme inhibitors or angiotensin receptor blockers after acute myocardial infarction (MI), the optimal dosing or the risk–benefit profile of different doses have not been fully identified. MET...
Gardado en:
Publicado en: | ESC Heart Fail |
---|---|
Main Authors: | , , , , , , , , , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado: |
John Wiley and Sons Inc.
2018
|
Assuntos: | |
Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5880661/ https://ncbi.nlm.nih.gov/pubmed/29341471 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.12249 |
Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|